Kentaro Enjo

Kentaro Enjo is a seasoned professional in the field of oncology medical affairs with extensive experience across prominent pharmaceutical companies. Currently serving as the Medical Affairs Director for Japan at Novocure since April 2023, Kentaro has held various significant roles including Head of GU&GI Scientific Experts at Bayer and multiple director positions at AstraZeneca and The Janssen Pharmaceutical Companies of Johnson & Johnson, focusing on lung cancer, genitourinary cancer, and hematology. Prior experience includes senior research roles at Astellas Pharma and Yamanouchi, along with a strong research background with over five years as a Preclinical Lead. Kentaro holds a Ph.D. in Medicine from Tohoku University and is a graduate of Tokyo Metropolitan Ryogoku High School.